20 agosto 2015
In advanced non-small cell lung cancer, the new tyrosine-kinase inhibitor is more effective than combination chemotherapy in patients with certain mutations, reviewers report.
http://www.sciencedaily.com/releases/2015/08/150820125837.htm
